Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oneness Biotech CoLUX:ONEA 59 Days Inventory is 404.27 as of Dec. 2025, which is 67% below its 10-year median of 1,226.39. GuruFocus rates LUX:ONEA with a GF Score™ of 59/100 and a GF Value™ of $35.65. The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, Oneness Biotech Co ranks worse than 80.88% on this metric.
The historical rank and industry rank for Oneness Biotech Co's Days Inventory or its related term are showing as below:
LUX:ONEA'
s Days Inventory Range Over the Past 10 Years
Min: 174.66 Med: 1226.39 Max: 12228.84
Current: 460.6
During the past 13 years, Oneness Biotech Co's highest Days Inventory was 12228.84. The lowest was 174.66. And the median was 1226.39.
LUX:ONEA's Days Inventory is ranked worse than 80.88% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs LUX:ONEA: 460.60
Oneness Biotech Co's Days Inventory
declined
from Dec. 2024 (490.80) to Dec. 2025 (404.27).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Oneness Biotech Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Oneness Biotech Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 2.61.
Oneness Biotech Co (LUX:ONEA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Oneness Biotech Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Oneness Biotech Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Oneness Biotech Co Days Inventory Related Terms
Oneness Biotech Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Oneness Biotech Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LUX:ONEA vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Oneness Biotech Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oneness Biotech Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Oneness Biotech Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oneness Biotech Co (LUX:ONEA) has a Days Inventory of 404.27 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Oneness Biotech Co and its competitors. This is 67% below median its historical median of 1,226.39. Over the past decade, Oneness Biotech Co's Days Inventory has ranged from 174.66 to 12,228.84. According to the industry distribution chart, Oneness Biotech Co ranks #516 out of 638 companies in the Biotechnology industry, placing it in the top 80.9%.
Is Oneness Biotech Co's Days Inventory too high?
Oneness Biotech Co's current Days Inventory of 404.27 is 67% below median its 10-year median of 1,226.39. Over the past 10 years, this metric has ranged from a low of 174.66 to a high of 12,228.84. The Biotechnology industry median Days Inventory is 183.20. Oneness Biotech Co's value of 404.27 is 120.7% above this industry median. Based on the distribution chart, Oneness Biotech Co ranks #516 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Oneness Biotech Co has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Oneness Biotech Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oneness Biotech Co ranks #516 out of 638 companies for Days Inventory. This places Oneness Biotech Co in the lower half of its industry. The industry median Days Inventory is 183.20. Oneness Biotech Co's value of 404.27 is 120.7% above this benchmark. Historically, Oneness Biotech Co's own Days Inventory has ranged from 174.66 to 12,228.84 over the past decade. While the company's 10-year median is 1,226.39 vs. the industry median of 183.20, Oneness Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oneness Biotech Co's current Days Inventory of 404.27 is 120.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Oneness Biotech Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oneness Biotech Co's current Days Inventory is 404.27, which is 67% below median its own 10-year median of 1,226.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneness Biotech Co stock overvalued right now?
Oneness Biotech Co (LUX:ONEA) has a current Days Inventory of 404.27. The stock's GF Value™ is $35.65, compared to a current price of $23.60 — trading 33.8% below its estimated fair value. The current Days Inventory is 404.27, which is 67% below median its 10-year median of 1,226.39 and 120.7% above the Biotechnology industry median of 183.20. Oneness Biotech Co's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Oneness Biotech Co (LUX:ONEA), the current Days Inventory is 404.27 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneness Biotech Co (LUX:ONEA) Overvalued in 2026?
Based on GuruFocus' analysis, Oneness Biotech Co stock appears to be undervalued.
The current stock price of $23.60 is trading 33.8% below its estimated GF Value™ of $35.65.
Key valuation signals for LUX:ONEA:
Days Inventory: 404.27 (67% below median its 10-year median of 1,226.39)
GF Value™: $35.65 vs. price of $23.60 (33.8% below fair value)
Industry Position: 120.7% above the Biotechnology median (#516 of 638)
No single metric tells the full story. See the LUX:ONEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The Group's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and Bonvadis, a wound care medical device. It also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, SNS851, and others. The Group operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation and organic food segment.
59GF Score
Get the complete analysis for LUX:ONEA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUX:ONEA has been successfully added to your 
